The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shao, W.-H.
Right arrow Articles by Haribabu, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shao, W.-H.
Right arrow Articles by Haribabu, B.
The Journal of Immunology, 2006, 176: 6254-6261.
Copyright © 2006 by The American Association of Immunologists

Targeted Disruption of Leukotriene B4 Receptors BLT1 and BLT2: A Critical Role for BLT1 in Collagen-Induced Arthritis in Mice1

Wen-Hai Shao*,{dagger}, Annalisa Del Prete*,{ddagger}, Cheryl B. Bock§ and Bodduluri Haribabu2,*,{dagger}

* James Graham Brown Cancer Center and {dagger} Department of Microbiology and Immunology, University of Louisville Health Sciences Center, Louisville, KY 40202; {ddagger} Section of Clinical Biochemistry, Department of Medical Biochemistry, University of Bari, Bari, Italy; and § Transgenic Mouse Core Facility, Duke University Medical Center, Durham, NC 27710

Leukotriene B4 mediates diverse inflammatory diseases through the G protein-coupled receptors BLT1 and BLT2. In this study, we developed mice deficient in BLT1 and BLT2 by simultaneous targeted disruption of these genes. The BLT1/BLT2 double-deficient mice developed normally and peritoneal exudate cells showed no detectable responses to leukotriene B4 confirming the deletion of the BLT1/BLT2 locus. In a model of collagen-induced arthritis on the C57BL/6 background, the BLT1/BLT2–/– as well as the previously described BLT1–/– animals showed complete protection from disease development. The disease severity correlated well with histopathology, including loss of joint architecture, inflammatory cell infiltration, fibrosis, pannus formation, and bone erosion in joints of BLT1/BLT2+/+ animals and a total absence of disease pathology in leukotriene receptor-deficient mice. Despite these differences, all immunized BLT1–/– and BLT1/BLT2–/– animals had similar serum levels of anti-collagen Abs relative to BLT1/BLT2+/+ animals. Thus, BLT1 may be a useful target for therapies directed at treating inflammation associated with arthritis.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Miyahara, H. Ohnishi, S. Miyahara, K. Takeda, S. Matsubara, H. Matsuda, M. Okamoto, J. E. Loader, A. Joetham, M. Tanimoto, et al.
Leukotriene B4 Release from Mast Cells in IgE-Mediated Airway Hyperresponsiveness and Inflammation
Am. J. Respir. Cell Mol. Biol., June 1, 2009; 40(6): 672 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. d. P. Conte, C. Barja-Fidalgo, W. A. Verri Jr., F. Q. Cunha, G. A. Rae, C. Penido, and M. d. G. M. O. Henriques
Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-{alpha}, and CXCL-1
J. Leukoc. Biol., September 1, 2008; 84(3): 652 - 660.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Okuno, Y. Iizuka, H. Okazaki, T. Yokomizo, R. Taguchi, and T. Shimizu
12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2
J. Exp. Med., April 14, 2008; 205(4): 759 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. T. G. Guerrero, W. A. Verri Jr., T. M. Cunha, T. A. Silva, I. R. S. Schivo, D. Dal-Secco, C. Canetti, F. A. C. Rocha, C. A. Parada, F. Q. Cunha, et al.
Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2
J. Leukoc. Biol., January 1, 2008; 83(1): 122 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet
G-protein-coupled receptor expression, function, and signaling in macrophages
J. Leukoc. Biol., July 1, 2007; 82(1): 16 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. L. Rao, P. J. Dunford, X. Xue, X. Jiang, K. A. Lundeen, F. Coles, J. P. Riley, K. N. Williams, C. A. Grice, J. P. Edwards, et al.
Anti-Inflammatory Activity of a Potent, Selective Leukotriene A4 Hydrolase Inhibitor in Comparison with the 5-Lipoxygenase Inhibitor Zileuton
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1154 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F. Diaz-Gonzalez, R. H E Alten, W. G Bensen, J. P Brown, J. T Sibley, M. Dougados, S. Bombardieri, P. Durez, P. Ortiz, G. de-Miquel, et al.
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
Ann Rheum Dis, May 1, 2007; 66(5): 628 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Basu, V. R. Jala, S. Mathis, S. T. Rajagopal, A. Del Prete, P. Maturu, J. O. Trent, and B. Haribabu
Critical Role for Polar Residues in Coupling Leukotriene B4 Binding to Signal Transduction in BLT1
J. Biol. Chem., March 30, 2007; 282(13): 10005 - 10017.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Del Prete, W.-H. Shao, S. Mitola, G. Santoro, S. Sozzani, and B. Haribabu
Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function
Blood, January 15, 2007; 109(2): 626 - 631.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.